Mount Logan Capital Inc. Reports Results of Election of Directors
Globenewswire· 2025-06-19 00:20
Company Overview - Mount Logan Capital Inc. is an alternative asset management and insurance solutions company focused on public and private debt securities in the North American market and reinsurance of annuity products through its subsidiaries [3][4] - The company actively sources, evaluates, underwrites, manages, monitors, and invests in loans, debt securities, and other credit-oriented instruments that offer attractive risk-adjusted returns with low risk of principal impairment [3] Shareholder Meeting - At the annual meeting of shareholders held on June 18, 2025, all six nominees listed in the management information circular were elected as directors, with a total of 31,979,130 votes cast, representing 55.78% of the issued and outstanding common shares [1] - The detailed voting results showed that Edward Goldthorpe, Perry Dellelce, and Sabrina Liak received 93.39% of votes in favor, while Rudolph Reinfrank, David Allen, and Buckley Ratchford received 95.95% [2] Auditor Re-appointment - Shareholders approved the re-appointment of Deloitte & Touche LLP as the auditor of Mount Logan Capital Inc. [2] Leadership Statement - CEO and Chairman Ted Goldthorpe expressed appreciation for the strong vote of confidence from shareholders, reaffirming the company's strategic course and commitment to transparent dialogue for disciplined growth [3]
AMC Networks Inc. Announces Pricing of Private Offering of $400 Million of 10.50% Senior Secured Notes due 2032
Globenewswire· 2025-06-19 00:10
Core Viewpoint - AMC Networks Inc. has priced an offering of $400 million in senior secured notes with a 10.50% interest rate due in 2032, which will be guaranteed by its domestic subsidiaries [1][2]. Group 1: Offering Details - The offering consists of $400 million aggregate principal amount of 10.50% senior secured notes due 2032 [1]. - The notes will be unconditionally guaranteed by AMC Networks' existing and future domestic subsidiaries on a senior secured basis [1]. Group 2: Use of Proceeds - The net proceeds from the notes offering will be used to fund a tender offer to purchase up to $450 million of outstanding 4.25% Senior Notes due 2029 [2]. - Additional uses of the proceeds include paying related premiums, fees, and expenses associated with the offering and the tender offer, as well as repurchasing or repaying other corporate indebtedness [2]. Group 3: Regulatory Information - The notes are being offered under an exemption from the Securities Act of 1933 and will not be registered under the Securities Act or any state securities laws [3]. - The initial purchasers will offer the notes only to qualified institutional buyers or outside the U.S. under specific regulations [3].
Reliance Global Group Announces Up To $6.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Globenewswire· 2025-06-18 23:00
Group 1 - Reliance Global Group, Inc. has announced a private placement for the issuance and sale of 1,488,096 shares of common stock and short-term warrants to purchase up to 2,976,192 shares at a price of $1.68 per share, with expected gross proceeds of approximately $2.5 million [1][3] - The short-term warrants will be exercisable at an exercise price of $1.43 per share and will expire two years from the effective date of the Resale Registration Statement [1][3] - The company intends to use the net proceeds from the offering for working capital and general corporate purposes [3] Group 2 - H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering [2] - The securities offered in the private placement are not registered under the Securities Act and are only available to accredited investors [4] - The company has agreed to file registration statements with the SEC covering the resale of the shares and shares issuable upon exercise of the warrants [4] Group 3 - Reliance Global Group, Inc. is an InsurTech pioneer utilizing AI and cloud-based technologies to enhance efficiencies in the insurance agency and brokerage industry [6] - The company's platform, RELI Exchange, provides independent insurance agencies with business development tools to compete effectively with larger agencies [6] - Reliance also operates a consumer platform, 5minuteinsure.com, which offers competitive online insurance quotes for auto, home, and life insurance [6]
NuVista Receives TSX Approval for the Renewal of its Normal Course Issuer Bid
Globenewswire· 2025-06-18 22:38
Core Viewpoint - NuVista Energy Ltd. has received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid (2025 NCIB), allowing the company to repurchase up to 16,398,617 common shares over the next year [1][2]. Group 1: Share Repurchase Details - The 2025 NCIB will be effective from June 23, 2025, until June 22, 2026, or until completed or terminated earlier by NuVista [2]. - The maximum number of shares to be repurchased represents 10% of the public float as of June 12, 2025, with a daily maximum purchase limit of 195,945 shares [4]. - NuVista has established an automatic share purchase plan (ASPP) to facilitate share repurchases during self-imposed blackout periods [5]. Group 2: Financial Commitments and Strategy - NuVista has already met its minimum share repurchase target of $100 million for the year, indicating a commitment to disciplined growth and returning capital to shareholders [3]. - For the remainder of the year, at least 75% of incremental free adjusted funds flow will be allocated to additional share buybacks [3]. - The previous normal course issuer bid (2024 NCIB) allowed for the repurchase of up to 14,234,451 shares, with 11,234,200 shares repurchased at a weighted average price of $12.76 [6]. Group 3: Company Overview - NuVista is engaged in the exploration, development, and production of oil and natural gas reserves in Alberta, focusing on the condensate-rich Montney formation [8]. - The company aims to create significant shareholder value through high-value condensate volumes associated with its natural gas production [8].
Tenaris provides information pursuant to Luxembourg Transparency Law
Globenewswire· 2025-06-18 22:23
LUXEMBOURG, June 18, 2025 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”, or the “Company”) announced today that the Company’s controlling shareholder, San Faustin S.A. (“San Faustin”), has notified the Company that, as a result of Tenaris’s open market repurchases of own shares under its share buyback program publicly announced on May 27, 2025, San Faustin has passively crossed a voting rights threshold triggering a notice requirement under the Luxembourg Transparency ...
Prime Drink Group Announces Launch of Rights Offering
Globenewswire· 2025-06-18 22:20
MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it is undertaking a rights offering (the “Rights Offering”). The Company will be offering a maximum of 353,409,888 rights (the “Rights”) to holders (the “Shareholders”) of its common shares (the “Shares”) as at the close of business on the record date of June 25, 2025 (the “Record Date”) on the basis of one (1) Right for each one (1) Share held. Each one (1) Right will entitle the holder ...
Euro Sun Mining Inc. Announces 2025 AGM Voting Results
Globenewswire· 2025-06-18 22:00
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to provide the voting results from its 2025 annual general meeting of shareholders in accordance with the policies of the Toronto Stock Exchange. The Company announces that the nominees listed in the management information circular dated May 8, 2025 (the “Circular”) for the 2025 annual general meeting of shareholders of the Company (the “Meeting”) were elected as directors of the Company. Shar ...
Carbon Streaming Announces Annual General Meeting Results
Globenewswire· 2025-06-18 22:00
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) today held its annual general meeting of shareholders (the “Meeting”), where each of the five nominees proposed as directors and listed in the Company’s management proxy circular dated May 6, 2025 were elected as directors. A total of 16,029,044 common shares were voted in respect of the election of directors at the Meeting, representing approximately 30.32 ...
Correction: Nyrstar NV – update with regards to candidacy of Mr. Kris Peeters as independent non-executive director
Globenewswire· 2025-06-18 21:56
Regulated information – inside information 18 June 2025 at 23:35 CEST Nyrstar NV – update with regards to candidacy of Mr. Kris Peeters as independent non-executive director Nyrstar NV (the “Company”) was informed this evening of the fact that Mr. Kris Peeters has withdrawn his candidacy to be appointed as independent non-executive director of Nyrstar NV. This decision was taken by Mr. Peeters on 18 June 2025 after reconsideration of his former mandate at the European Investment Bank, of which Mr. Peeters s ...
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
Globenewswire· 2025-06-18 21:36
Core Viewpoint - Psyence Group Inc. is conducting a non-brokered private placement to raise up to C$600,000 through the issuance of 6,000,000 common shares at C$0.10 each, aimed at pursuing strategic transactions and general operational needs [1][2]. Group 1 - The offering is expected to close around June 25, 2025, pending necessary regulatory approvals [3]. - The net proceeds will be utilized for evaluating potential acquisitions and business combinations, as well as for general administrative expenses and maintaining listing status [2][4]. - The securities issued will be subject to a statutory hold period of four months and one day, with potential extensions if a significant transaction occurs [4]. Group 2 - Psyence Group focuses on developing nature-derived psilocybin products for mental health treatment, particularly in palliative care contexts [5][6]. - The company emphasizes its commitment to evidence-based research in the production of psychedelic medicines [5].